Latest Food & Drug Administration news
FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Pfizer Pill as First At-Home COVID-19 Treatment
posted December 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First-in-Class Treatment for Myasthenia Gravis
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Pfizer Boosters for Teens Aged 16 to 17
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
